Cargando...

Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium species

Several promising antimalarial drugs are currently being tested in human trials, such as artefenomel, cipargamin, ferroquine and ganaplacide. Many of these compounds were identified using high throughput screens against a single species of human malaria, Plasmodium falciparum, under the assumption t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Parasitol Drugs Drug Resist
Autores principales: van Schalkwyk, Donelly A., Moon, Robert W., Duffey, Maëlle, Leroy, Didier, Sutherland, Colin J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8327131/
https://ncbi.nlm.nih.gov/pubmed/34315108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2021.07.002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!